title: Cyclic 1,2-diketones as core building blocks: a strategy for the total synthesis of (-)-terpestacin.
abstract: We report a full account of our work towards the total synthesis of (-)-terpestacin (1), a sesterterpene originally isolated from fungal strain Arthrinium sp. FA1744. Its promising anti-HIV and anti-cancer activity, as well as its novel structure, make terpestacin an attractive synthetic target. A strategy based on the unique reactivity of cyclic 1,2-diketones (diosphenols) was developed and total synthesis of 1 was achieved in 20 steps, in the longest linear sequence, from commercially available 2-hydroxy-3-methyl-2-cyclopenten-1-one. The key feature of our synthesis is the double usage of a "Pd AAA-Claisen" protocol (AAA=asymmetric allylic alkylation), first in the early stages to generate the C1 quaternary center and then in the late stages to install the side chain. In addition, a rather unusual ene-1,2-dione moiety was synthesized and utilized as an excellent Michael acceptor to attach the C15 substituent. Several possible routes towards the total synthesis have been examined and carefully evaluated. During our exploration many interesting chemoselectivity issues have been addressed, such as a highly selective ring-closing metathesis and a challenging oxidation of a disubstituted olefin in the presence of three trisubstituted ones.
authors.affiliation: Department of Chemistry, Stanford University, Stanford, California 94305-5080, USA. bmtrost@stanford.edu
authors.forename: Barry M
authors.initials: BM
authors.lastname: Trost
authors.forename: Guangbin
authors.initials: G
authors.lastname: Dong
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Vance
mesh_terms: D000478:Alkylation; D001643:Bridged Bicyclo Compounds / Q000138:chemical synthesis / Q000737:chemistry; D002384:Catalysis; D007659:Ketones / Q000737:chemistry*; D010084:Oxidation-Reduction; D010165:Palladium / Q000737:chemistry; D013237:Stereoisomerism
chemical_list: D001643:Bridged Bicyclo Compounds; D007659:Ketones; C080890:terpestacin; D010165:Palladium
references.citation: J Am Chem Soc. 2003 Sep 24;125(38):11514-5
references.pmid: 13129351
references.citation: J Am Chem Soc. 2007 Apr 18;129(15):4540-1
references.pmid: 17343388
references.citation: J Basic Microbiol. 2001;41(3-4):179-83
references.pmid: 11512450
references.citation: Org Lett. 2005 Mar 31;7(7):1415-7
references.pmid: 15787520
references.citation: J Antibiot (Tokyo). 1998 Jun;51(6):602-6
references.pmid: 9711228
references.citation: J Org Chem. 2003 Oct 17;68(21):8092-6
references.pmid: 14535788
references.citation: Angew Chem Int Ed Engl. 2002 Mar 15;41(6):993-6
references.pmid: 12491291
references.citation: J Antibiot (Tokyo). 2003 May;56(5):492-6
references.pmid: 12870816
references.citation: J Antibiot (Tokyo). 1993 Mar;46(3):367-73
references.pmid: 8478254
references.citation: Angew Chem Int Ed Engl. 2006 Sep 4;45(35):5837-42
references.pmid: 16874828
references.citation: J Org Chem. 2001 Dec 14;66(25):8646-9
references.pmid: 11735551
references.citation: J Org Chem. 2007 Aug 17;72(17):6473-80
references.pmid: 17630803
references.citation: J Am Chem Soc. 2002 Apr 24;124(16):4230-2
references.pmid: 11960450
references.citation: Biosci Biotechnol Biochem. 2002 Mar;66(3):685-8
references.pmid: 12005073
references.citation: Org Lett. 1999 Sep 23;1(6):953-6
references.pmid: 10823227
references.citation: J Am Chem Soc. 2004 Sep 1;126(34):10682-91
references.pmid: 15327327